Paul Yook, 10% Owner at Novus Therapeutics, Inc. (NVUS), sold 200 shares at $2.70 ($540) on 2019-04-30, disclosed to the SEC on 2019-05-02.
Open-market sale of $540 NVUS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.